NALM6 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1122-YF4827
Target Cell Organism: Human
Target Cell Alternative Name: NALM-6
Target Cell Name: NALM6
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NALM6-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NALM6
Target Cell Organism
Human
Target Cell Background
Nalm6 is a B cell precursor leukemia cell line initiated from an adolescent male. It is a CD24-positive xenograft model of acute lymphoblastic leukemia.
Target Cell Alternative Name
NALM-6
Related Diseases
Acute lymphoblastic leukemia; ALL
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
NALM6-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry